Literature DB >> 25147072

Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure.

John Papanikolaou1, Vasiliki Tsolaki2, Demosthenes Makris3, Epaminondas Zakynthinos4.   

Abstract

Entities:  

Keywords:  Acute heart failure; Cardiogenic shock; Levosimendan; Neurogenic stress cardiomyopathy; Outcome; Subarachnoid hemorrhage

Mesh：

Substances：

Year:  2014        PMID： 25147072     DOI： 10.1016/j.ijcard.2014.08.039

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

1.  Neurogenic Stunned Myocardium in Two Children with Neurological Injury.

Authors:  Laura Díaz Ruiz; Iria Durán Lorenzo; Olga Ordoñez Sáez
Journal:  J Pediatr Intensive Care       Date:  2019-07-14

2.  Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.

Authors:  Dariusz Onichimowski; Krzysztof Nosek; Radosław Goraj; Rakesh Jalali; Aleksandra Wińska; Aleksandra Pawlos; Bułat Tuyakov
Journal:  Drug Des Devel Ther       Date:  2018-06-20       Impact factor: 4.162

Review 3.  Sepsis-Induced Cardiomyopathy: Oxidative Implications in the Initiation and Resolution of the Damage.

Authors:  Vasiliki Tsolaki; Demosthenes Makris; Konstantinos Mantzarlis; Epameinontas Zakynthinos
Journal:  Oxid Med Cell Longev       Date:  2017-09-19       Impact factor: 6.543

Review 4.  Heart failure in COVID-19 patients: Critical care experience.

Authors:  Kevin John John; Ajay K Mishra; Chidambaram Ramasamy; Anu A George; Vijairam Selvaraj; Amos Lal
Journal:  World J Virol       Date:  2022-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.